In this issue:
Risk of eczema with paracetamol debunked
Dupilumab does not require routine laboratory monitoring
Antenatal prebiotic supplementation does not prevent AD in high-risk infants
Bathing frequency does not substantially impact AD severity
Baricitinib outperforms azathioprine for moderate-to-severe AD
Severe AD linked to increased risk of VTE
Topical delgocitinib safe and efficacious for chronic hand eczema
Allergic comorbidities are common in paediatric AD
Biomarkers cannot differentiate clinical ICD from ACD
Evolving contact dermatitis allergen profiles in CAD
Please login below to download this issue (PDF)